Overview

Sanofi-Aventis U.S. LLC is the U.S. subsidiary of Sanofi, a multinational pharmaceutical company headquartered in Paris, France. The company is engaged in the research, development, manufacturing, and marketing of healthcare products, with a strong emphasis on innovative solutions in various therapeutic areas.

Therapeutic areas

Active pharmaceutical ingredients supplied

Substances Sanofi-Aventis U.S. LLC is evidenced to supply (US FDA Drug Master File or EU CEP). Open any ingredient to see its full supplier landscape, CAS number and patent status.

FDA compliance signals

22 FDA enforcement records linked to this company.

  • recall — Class II2023-05-24

    Lack of Assurance of Sterility: Malformed crimped collar seal

  • recall — Class II2020-08-26

    Failed Stability Specifications: Out of Specification result for enzyme activity levels noted during routine stability testing.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2019-12-11

    CGMP Deviations: Presence of NDMA impurity detected in product.

  • recall — Class II2018-07-18

    Temperature Abuse: Product samples of Admelog may not have been shipped at proper temperature.

Verified Supplier Partner

Is this Sanofi-Aventis U.S. LLC? Get in front of buyers actively sourcing.

We route real sourcing requests from pharma buyers to vetted, verified partners — qualified leads, not just a listing. Tell us what you make and we'll be in touch about becoming a Verified Supplier Partner.

No cost to enquire · we only reach out with a fit.

Ready to Accelerate Your
Discovery Workflow?

Find, vet, and source drug-manufacturing partners faster — with FDA compliance screening built in. Start free for 7 days.